GMAB (GMAB) Earnings Call Analysis

23/25

Growth 5 Margin 5 Expansion 5 Platform 3 Financial 5

latest quarter score

Earnings Reports

23
GENMAP (GMAB) Q2 2026: Epkinley Sales Surge 48%, Pipeline Readouts Set Stage for 2027 Launches
August 07, 2026
23
Genmab (GMAB) Q1 2026: Epkinley Drives 52% Global Growth, Pipeline Readouts Set Up Multi-Asset Launches
May 07, 2026
21
Genmab (GMAB) Q4 2025: Proprietary Medicine Sales Jump 54% as Pipeline Readouts Set Up 2027 Launch Wave
February 23, 2026
22
Genmab (GMAB) Q3 2025: Operating Profit Jumps 52% as Proprietary Portfolio Scales and Merus Deal Reshapes Pipeline
November 07, 2025
22
Genmab (GMAB) Q2 2025: Recurring Revenues Rise 22% as Pipeline Advances Fuel Expansion
August 07, 2025
21
Genmab (GMAB) Q1 2025: 19% Revenue Growth Driven by Epkinly and Tivdak Expansion
May 08, 2025

Browse all companies